Logo image of MRC

MRC GLOBAL INC (MRC) Stock Fundamental Analysis

NYSE:MRC - New York Stock Exchange, Inc. - US55345K1034 - Common Stock - Currency: USD

12.18  -0.59 (-4.62%)

After market: 12.18 0 (0%)

Fundamental Rating

4

MRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Trading Companies & Distributors industry. MRC has only an average score on both its financial health and profitability. MRC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MRC had positive earnings in the past year.
In the past year MRC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MRC reported negative net income in multiple years.
Of the past 5 years MRC 4 years had a positive operating cash flow.
MRC Yearly Net Income VS EBIT VS OCF VS FCFMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

1.2 Ratios

With a Return On Assets value of 4.27%, MRC perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Return On Equity of MRC (8.22%) is worse than 64.58% of its industry peers.
With a decent Return On Invested Capital value of 8.80%, MRC is doing good in the industry, outperforming 60.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MRC is in line with the industry average of 9.86%.
Industry RankSector Rank
ROA 4.27%
ROE 8.22%
ROIC 8.8%
ROA(3y)1.73%
ROA(5y)-2.18%
ROE(3y)3.98%
ROE(5y)-5.76%
ROIC(3y)9.39%
ROIC(5y)7.01%
MRC Yearly ROA, ROE, ROICMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

1.3 Margins

MRC has a worse Profit Margin (2.34%) than 64.58% of its industry peers.
In the last couple of years the Profit Margin of MRC has grown nicely.
With a Operating Margin value of 4.75%, MRC is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
MRC's Operating Margin has improved in the last couple of years.
MRC has a Gross Margin of 20.42%. This is in the lower half of the industry: MRC underperforms 79.17% of its industry peers.
MRC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.75%
PM (TTM) 2.34%
GM 20.42%
OM growth 3Y36.3%
OM growth 5Y12.72%
PM growth 3YN/A
PM growth 5Y17.09%
GM growth 3Y2.77%
GM growth 5Y4.13%
MRC Yearly Profit, Operating, Gross MarginsMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

6

2. Health

2.1 Basic Checks

MRC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MRC has been increased compared to 1 year ago.
The number of shares outstanding for MRC has been reduced compared to 5 years ago.
The debt/assets ratio for MRC has been reduced compared to a year ago.
MRC Yearly Shares OutstandingMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MRC Yearly Total Debt VS Total AssetsMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.71 indicates that MRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.71, MRC is in line with its industry, outperforming 47.92% of the companies in the same industry.
MRC has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.33, MRC belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that MRC is not too dependend on debt financing.
The Debt to Equity ratio of MRC (0.09) is better than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.33
Altman-Z 2.71
ROIC/WACC0.79
WACC11.09%
MRC Yearly LT Debt VS Equity VS FCFMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.99 indicates that MRC should not have too much problems paying its short term obligations.
The Current ratio of MRC (1.99) is comparable to the rest of the industry.
A Quick Ratio of 1.11 indicates that MRC should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.11, MRC is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.11
MRC Yearly Current Assets VS Current LiabilitesMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

More info and screens

3

3. Growth

3.1 Past

MRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.66%.
The Earnings Per Share has been growing by 14.07% on average over the past years. This is quite good.
Looking at the last year, MRC shows a decrease in Revenue. The Revenue has decreased by -8.82% in the last year.
The Revenue has been decreasing by -3.94% on average over the past years.
EPS 1Y (TTM)-20.66%
EPS 3YN/A
EPS 5Y14.07%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)-8.82%
Revenue growth 3Y10.05%
Revenue growth 5Y-3.94%
Sales Q2Q%-10.25%

3.2 Future

MRC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.94% yearly.
The Revenue is expected to grow by 0.71% on average over the next years.
EPS Next Y-29.21%
EPS Next 2Y-1.54%
EPS Next 3Y5.98%
EPS Next 5Y5.94%
Revenue Next Year-8.48%
Revenue Next 2Y-3.78%
Revenue Next 3Y-0.71%
Revenue Next 5Y0.71%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MRC Yearly Revenue VS EstimatesMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
MRC Yearly EPS VS EstimatesMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

MRC is valuated correctly with a Price/Earnings ratio of 12.69.
Compared to the rest of the industry, the Price/Earnings ratio of MRC indicates a somewhat cheap valuation: MRC is cheaper than 79.17% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, MRC is valued rather cheaply.
The Price/Forward Earnings ratio is 11.22, which indicates a very decent valuation of MRC.
MRC's Price/Forward Earnings ratio is rather cheap when compared to the industry. MRC is cheaper than 83.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, MRC is valued rather cheaply.
Industry RankSector Rank
PE 12.69
Fwd PE 11.22
MRC Price Earnings VS Forward Price EarningsMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MRC is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MRC is valued cheaper than 97.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.02
EV/EBITDA 5.5
MRC Per share dataMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y-1.54%
EPS Next 3Y5.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MRC GLOBAL INC

NYSE:MRC (2/21/2025, 8:04:00 PM)

After market: 12.18 0 (0%)

12.18

-0.59 (-4.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners96.47%
Inst Owner Change-88.04%
Ins Owners1.61%
Ins Owner Change2.64%
Market Cap1.04B
Analysts85
Price Target17.6 (44.5%)
Short Float %1.8%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.29
Dividend Growth(5Y)1%
DP32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.35%
Min EPS beat(2)14.64%
Max EPS beat(2)18.05%
EPS beat(4)4
Avg EPS beat(4)43.19%
Min EPS beat(4)14.64%
Max EPS beat(4)95.19%
EPS beat(8)6
Avg EPS beat(8)17.49%
EPS beat(12)10
Avg EPS beat(12)77.04%
EPS beat(16)14
Avg EPS beat(16)71.89%
Revenue beat(2)0
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-0.91%
Max Revenue beat(2)-0.64%
Revenue beat(4)1
Avg Revenue beat(4)-0.73%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)4.9%
Revenue beat(8)2
Avg Revenue beat(8)-1.75%
Revenue beat(12)5
Avg Revenue beat(12)-0.68%
Revenue beat(16)8
Avg Revenue beat(16)0.15%
PT rev (1m)0%
PT rev (3m)2.99%
EPS NQ rev (1m)-31.25%
EPS NQ rev (3m)-31.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.8%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 12.69
Fwd PE 11.22
P/S 0.32
P/FCF 4.02
P/OCF 3.63
P/B 1.14
P/tB 2.08
EV/EBITDA 5.5
EPS(TTM)0.96
EY7.88%
EPS(NY)1.09
Fwd EY8.91%
FCF(TTM)3.03
FCFY24.85%
OCF(TTM)3.36
OCFY27.55%
SpS37.58
BVpS10.7
TBVpS5.87
PEG (NY)N/A
PEG (5Y)0.9
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.22%
ROCE 12.34%
ROIC 8.8%
ROICexc 9.27%
ROICexgc 14.31%
OM 4.75%
PM (TTM) 2.34%
GM 20.42%
FCFM 8.05%
ROA(3y)1.73%
ROA(5y)-2.18%
ROE(3y)3.98%
ROE(5y)-5.76%
ROIC(3y)9.39%
ROIC(5y)7.01%
ROICexc(3y)10.1%
ROICexc(5y)7.51%
ROICexgc(3y)16.81%
ROICexgc(5y)12.53%
ROCE(3y)13.16%
ROCE(5y)9.83%
ROICexcg growth 3Y68.31%
ROICexcg growth 5Y22.64%
ROICexc growth 3Y63.68%
ROICexc growth 5Y22.77%
OM growth 3Y36.3%
OM growth 5Y12.72%
PM growth 3YN/A
PM growth 5Y17.09%
GM growth 3Y2.77%
GM growth 5Y4.13%
F-Score7
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.33
Debt/EBITDA 0.44
Cap/Depr 68.29%
Cap/Sales 0.87%
Interest Coverage 6.08
Cash Conversion 148.19%
Profit Quality 344%
Current Ratio 1.99
Quick Ratio 1.11
Altman-Z 2.71
F-Score7
WACC11.09%
ROIC/WACC0.79
Cap/Depr(3y)29.65%
Cap/Depr(5y)28.29%
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.66%
EPS 3YN/A
EPS 5Y14.07%
EPS Q2Q%-31.25%
EPS Next Y-29.21%
EPS Next 2Y-1.54%
EPS Next 3Y5.98%
EPS Next 5Y5.94%
Revenue 1Y (TTM)-8.82%
Revenue growth 3Y10.05%
Revenue growth 5Y-3.94%
Sales Q2Q%-10.25%
Revenue Next Year-8.48%
Revenue Next 2Y-3.78%
Revenue Next 3Y-0.71%
Revenue Next 5Y0.71%
EBIT growth 1Y-26.57%
EBIT growth 3Y50%
EBIT growth 5Y8.28%
EBIT Next Year5.88%
EBIT Next 3Y6.89%
EBIT Next 5Y6.59%
FCF growth 1Y13000%
FCF growth 3Y-12.76%
FCF growth 5YN/A
OCF growth 1Y2760%
OCF growth 3Y-11.49%
OCF growth 5YN/A